tirzepatide cardiovascular outcome trial cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says tirzepatide outcomes trial results – An Observational Study of Cardiovascular
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4

























